Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long COIN Daily ETF vs Charles River Laboratories Intl. Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $5.31 (market cap $510.01M), while Charles River Laboratories Intl. Inc trades at $304.89 (market cap $14.23B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 27.9× GraniteShares 2x Long COIN Daily ETF's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long COIN Daily ETF for 15 Days and Charles River Laboratories Intl. Inc for 33 Days on average.
| CONL | CRL | |
|---|---|---|
Market Cap | $510.01M | $14.23B |
Volume | 21,041,836 | 1,176,885 |
Sector | Leveraged / Inverse | Health |
52-Week High | $48.58 | $310.77 |
52-Week Low | $3.93 | $149.93 |
Typical Hold Time | 15 Days | 33 Days |
Enterprise Value | — | $17.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CONL (GraniteShares 2x Long COIN Daily ETF) trades at $4.91, down 6.12% with bearish technical signals from moving averages. The ETF tracks Coinbase stock with 2x daily leverage, amplifying volatility. Recent news highlights significant price gaps and performance swings, with one article noting an 85% decline when Coinbase fell 50%. Technical indicators show oversold conditions with RSI readings below 30, suggesting potential near-term bounce.
Outlook remains highly speculative due to leveraged structure and dependency on Coinbase performance. Investment opportunity exists for tactical traders betting on Coinbase recovery, but risks include amplified losses, daily rebalancing decay, and crypto market volatility. Conservative investors should avoid due to extreme risk profile.
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →
